Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Common Stock Repurchased by Quarter
Common Stock Repurchased — Weighted-Average Price per Share (8-K) ($)
Elevance Health Common Stock Repurchased: $399 in Q3 2026, up 31.4% from a year earlier.
Latest, Q3 2026
399
Period ended Sep 30, 2026
Change on a year earlier
+31.4%
303 in Q3 2025
History
35 quarters
Since Q4 2017
Sources
35
Documents cited below
Where the Q3 2026 figure comes from
“During the third quarter of 2026, the Company repurchased 0.8 million shares of its common stock for $330 million, at a weighted average price of $398.75 per share, and paid a quarterly dividend of $1.”
Source: 8-K ER (FY2026Q3, 2026-10-21) ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Elevance Health Common Stock Repurchased ($), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/buyback-weighted-avg-price-8k
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.